Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISTA: Vornorexant for Insomnia and Daytime Impairment
jRCTs021260027Recruiting
- Sponsor
- Taisho Pharmaceutical
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vornorexant in Insomnia (2 arms), sponsored by Taisho Pharmaceutical. Primary endpoint: Change in Insomnia Severity Index (ISI) total score. Started Jul 2026; status: recruiting.
02
Drugs
vornorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCTs021260027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021260027.